Literature DB >> 11266063

Upregulation of mRNA of interleukin-1 and -6 in subchondral cystic lesions of four horses.

B von Rechenberg1, C Leutenegger, K Zlinsky, C W McIlwraith, M K Akens, J A Auer.   

Abstract

This study investigated the potential association of interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in subchondral cystic lesions (SCL) in horses. With the technique of in situ hybridisation in paraffin sections of fibrous tissue of SCL and quantitative real-time PCR in fresh frozen fibrous tissue and undecalcified bone sections of SCL embedded in acrylic resin, upregulation of mRNA of both cytokines could be demonstrated. mRNA of IL-1beta was upregulated at the periphery of the cystic lesion adjacent to normal bone, whereas IL-6 mRNA was upregulated within the fibrous tissue found within the centre of the SCL. It was concluded that both cytokines are associated in pathological bone resorption observed in SCL and, in combination with increased production of prostaglandin E2, may be responsible for the slow healing, maintenance or further expansion of the cystic lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266063     DOI: 10.1111/j.2042-3306.2001.tb00592.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  9 in total

1.  Subchondral cysts in dysplastic osteoarthritic hips communicate with the joint space: analysis using three-dimensional computed tomography.

Authors:  Ami Inui; Shunji Nakano; Shinji Yoshioka; Tomohiro Goto; Daisuke Hamada; Yoshiteru Kawasaki; Hiroshi Egawa; Natsuo Yasui
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-27

2.  Osseointegration of titanium implants functionalised with phosphoserine-tethered poly(epsilon-lysine) dendrons: a comparative study with traditional surface treatments in sheep.

Authors:  Stefan Stübinger; Katja Nuss; Alexander Bürki; Isabel Mosch; Miché le Sidler; Steve T Meikle; Brigitte von Rechenberg; Matteo Santin
Journal:  J Mater Sci Mater Med       Date:  2015-02-03       Impact factor: 3.896

3.  Osseointegration and biocompatibility of different metal implants--a comparative experimental investigation in sheep.

Authors:  Michael Plecko; Christine Sievert; Daniel Andermatt; Robert Frigg; Peter Kronen; Karina Klein; Stefan Stübinger; Katja Nuss; Alexander Bürki; Stephen Ferguson; Ulrich Stoeckle; Brigitte von Rechenberg
Journal:  BMC Musculoskelet Disord       Date:  2012-03-08       Impact factor: 2.362

4.  Evaluation of suitable reference genes for gene expression studies in bronchoalveolar lavage cells from horses with inflammatory airway disease.

Authors:  Laura Beekman; Triin Tohver; Rkia Dardari; Renaud Léguillette
Journal:  BMC Mol Biol       Date:  2011-01-28       Impact factor: 2.946

5.  Selection of a set of reliable reference genes for quantitative real-time PCR in normal equine skin and in equine sarcoids.

Authors:  Lies Bogaert; Mario Van Poucke; Cindy De Baere; Luc Peelman; Frank Gasthuys; Ann Martens
Journal:  BMC Biotechnol       Date:  2006-04-27       Impact factor: 2.563

6.  Long term in-vivo studies of a photo-oxidized bovine osteochondral transplant in sheep.

Authors:  M K Akens; B von Rechenberg; P Bittmann; D Nadler; K Zlinszky; J A Auer
Journal:  BMC Musculoskelet Disord       Date:  2001-11-30       Impact factor: 2.362

Review 7.  The biology and clinical evidence of microfracture in hip preservation surgery.

Authors:  Chadwick John Green; Aswin Beck; David Wood; Ming H Zheng
Journal:  J Hip Preserv Surg       Date:  2016-02-26

Review 8.  Cyst formation in the subchondral bone following cartilage repair.

Authors:  Liang Gao; Magali Cucchiarini; Henning Madry
Journal:  Clin Transl Med       Date:  2020-12

9.  SIRT1+ Adipose Derived Mesenchymal Stromal Stem Cells (ASCs) Suspended in Alginate Hydrogel for the Treatment of Subchondral Bone Cyst in Medial Femoral Condyle in the Horse. Clinical Report.

Authors:  Paweł Golonka; Katarzyna Kornicka-Garbowska; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-12       Impact factor: 5.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.